Healwell AI Inc (6H90.SG)
EUR 0.79
(-3.17%)
EUR 0.79
(-3.17%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -16.11 Million EUR | -7.36% |
| 2022 | -13.91 Million CAD | -23.78% |
| 2021 | -11.51 Million CAD | -673.83% |
| 2020 | 2.11 Million CAD | -42.0% |
| 2019 | 3.62 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -5.05 Million CAD | -17.9% |
| 2024 Q1 | -3.79 Million CAD | 0.0% |
| 2023 Q4 | - EUR | 100.0% |
| 2023 FY | - EUR | 100.0% |
| 2023 Q3 | -4.74 Million CAD | -40.24% |
| 2023 Q2 | -3.38 Million CAD | -32.45% |
| 2023 Q1 | -2.55 Million CAD | 31.08% |
| 2022 FY | - CAD | -23.78% |
| 2022 Q4 | -3.7 Million CAD | 0.0% |
| 2021 FY | - CAD | -673.83% |
| 2020 FY | - CAD | -42.0% |
| 2019 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Koskisen Corp | 35.85 Million EUR | 144.944% |